Citigroup Inc Abbott Laboratories Call Options Transaction History

Citigroup Inc

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 12, 2024	SELL	$100.07 - $118.13 $8.43 Million - $9.95 Million	-84,200 Reduced 54.85%	69,300 $7.9 Million
Q2 2024 Aug 12, 2024	SELL	$100.73 - $112.44 $4.36 Million - $4.87 Million	-43,300 Reduced 22.0%	153,500 $16 Million
Q1 2024 May 10, 2024	SELL	$109.52 - $120.96 $5.19 Million - $5.73 Million	-47,400 Reduced 19.41%	196,800 $22.4 Million
Q4 2023 Feb 09, 2024	BUY	$90.19 - $110.4 $1.63 Million - $2 Million	18,100 Added 8.01%	244,200 $26.9 Million
Q3 2023 Nov 09, 2023	BUY	$95.53 - $114.62 $8.51 Million - $10.2 Million	89,100 Added 65.04%	226,100 $21.9 Million
Q2 2023 Aug 10, 2023	SELL	$100.78 - $112.29 $1.52 Million - $1.7 Million	-15,100 Reduced 9.93%	137,000 $14.9 Million
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $15.6 Million - $18.3 Million	-160,600 Reduced 51.36%	152,100 $15.4 Million
Q4 2022 Feb 09, 2023	BUY	$95.06 - $111.52 $18.3 Million - $21.4 Million	192,100 Added 159.29%	312,700 $34.3 Million
Q3 2022 Nov 10, 2022	SELL	$96.76 - $112.03 $851,488 - $985,864	-8,800 Reduced 6.8%	120,600 $11.7 Million
Q2 2022 Aug 10, 2022	SELL	$102.07 - $123.37 $7.61 Million - $9.2 Million	-74,600 Reduced 36.57%	129,400 $14.1 Million
Q1 2022 May 12, 2022	BUY	$114.02 - $139.04 $4.73 Million - $5.77 Million	41,500 Added 25.54%	204,000 $24.1 Million
Q4 2021 Feb 10, 2022	SELL	$115.53 - $141.46 $2.15 Million - $2.63 Million	-18,600 Reduced 10.27%	162,500 $22.9 Million
Q3 2021 Nov 10, 2021	BUY	$116.66 - $129.06 $21.1 Million - $23.4 Million	181,100 New	181,100 $21.4 Million

3,187

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.